Celgene - The biopharmaceutical company declined after it reported quarterly revenue below forecasts.
Diamond Offshore Drilling - The offshore rig contractor rose after posting better-than-expected first-quarter profit.
Elizabeth Arden - The cosmetics company spiked on a Reuters report it hired Goldman Sachs to explore a sale.
Freeport-McMoRan Copper & Gold - The miner rose as its first-quarter profit decline wasn't as bad as feared.
JetBlue Airways - The carrier declined after reporting lower quarterly profit that fell short of street forecasts.
Johnson & Johnson - The health care company moved off its lows after announcing it would raise its quarterly dividend by 6.1 percent to 70 cents a share.
Lorillard - The cigarette seller fell after its first-quarter earnings sank 17 percent.
Netflix -The provider of online entertainment continued to fall after Amazon.com and HBO on Wednesday announced a licensing deal that poses a competitive threat to the company.
O'Reilly Automotive - The automotive supplier fell after guiding second-quarter and full-year forecasts below forecasts.
Penske Automotive Group - The automotive retailer and and Group 1 Automotive both advanced on better-than-expected first-quarter earnings.
Raytheon - The defense contractor fell after posting weaker-than-expected first-quarter earnings. Lockheed Martin, General Dynamics, Northrop Grumman and Rockwell Collins also fell.
Sotheby's - The auction house rose after Institutional Shareholder Services advised shareholders to vote for two of three board candidates proposed by activist investor Dan Loeb.
Southwest Airlines - The carrier gained after its first-quarter earnings more than doubled.
Stanley Black & Decker - The industrial tool maker gained after posting better-than-expected first-quarter earnings.
Under Armour - The maker of athletic wear fell despite strong first-quarter earnings as it warned that growth in 2014 might not be as strong as last year.
Zimmer Holdings - The orthopedic-device maker rallied after it said it would acquire rival Biomet for more than $13 billion.
(Read More: See CNBC's Market Insider Blog)
—By CNBC's Rich Fisherman.
Questions? Comments? Email us at firstname.lastname@example.org